Terug
Dagbereik
€ 86,64
€ 88,72
52-Weeksbereik
€ 81,36
€ 118,30
Volume
664.878
50D / 200D Gem.
€ 100,54
/
€ 95,51
Vorige Slotkoers
€ 85,94
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 40,3 | 0,4 |
| P/B | 1,3 | 2,9 |
| ROE % | 3,2 | 3,7 |
| Net Margin % | 8,5 | 3,8 |
| Rev Growth 5Y % | -7,1 | 10,0 |
| D/E | 0,5 | 0,2 |
Belangrijkste Punten
Revenue declined -7,06% annually over 5 years
Earnings declined -18,31% over the past year
ROE of 3,24% is below average
Debt/Equity of 0,48 — conservative balance sheet
Generating 508,26M in free cash flow
P/E of 40,32 — premium valuation
Groei
Revenue Growth (5Y)
-7,06%
Revenue (1Y)3,67%
Earnings (1Y)-18,31%
FCF Growth (3Y)616,37%
Kwaliteit
Return on Equity
3,24%
ROIC2,48%
Net Margin8,46%
Op. Margin12,49%
Veiligheid
Debt / Equity
0,48
Current Ratio1,68
Interest Coverage3,87
Waardering
P/E Ratio
40,32
P/B Ratio1,34
EV/EBITDA34,60
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,67% | Revenue Growth (3Y) | 1,90% |
| Earnings Growth (1Y) | -18,31% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -7,06% | Earnings Growth (5Y) | -28,85% |
| Profitability | |||
| Revenue (TTM) | 2,86B | Net Income (TTM) | 241,68M |
| ROE | 3,24% | ROA | 1,99% |
| Gross Margin | 53,08% | Operating Margin | 12,49% |
| Net Margin | 8,46% | Free Cash Flow (TTM) | 508,26M |
| ROIC | 2,48% | FCF Growth (3Y) | 616,37% |
| Safety | |||
| Debt / Equity | 0,48 | Current Ratio | 1,68 |
| Interest Coverage | 3,87 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 40,32 | P/B Ratio | 1,34 |
| P/S Ratio | 3,41 | PEG Ratio | -3,32 |
| EV/EBITDA | 34,60 | Dividend Yield | 0,00% |
| Market Cap | 9,74B | Enterprise Value | 12,34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,86B | 2,76B | 2,75B | 3,31B | 3,83B |
| Net Income | 241,68M | 295,83M | -118,38M | 569,18M | 943,16M |
| EPS (Diluted) | 2,08 | 2,41 | -0,95 | 4,50 | 8,08 |
| Gross Profit | 1,52B | 1,32B | 1,32B | 1,76B | 2,28B |
| Operating Income | 356,64M | 410,52M | 399,49M | 781,12M | 1,34B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12,17B | 12,39B | 13,56B | 14,13B | 15,00B |
| Total Liabilities | 4,92B | 4,73B | 5,69B | 6,75B | 7,86B |
| Shareholders' Equity | 7,25B | 7,67B | 7,87B | 7,38B | 7,14B |
| Total Debt | 3,52B | 3,33B | 4,07B | 4,60B | 5,16B |
| Cash & Equivalents | 919,87M | 1,16B | 913,16M | 454,36M | 603,32M |
| Current Assets | 2,24B | 2,35B | 3,00B | 3,29B | 2,44B |
| Current Liabilities | 1,33B | 653,10M | 1,45B | 1,54B | 1,21B |